NfL protein levels in CSF were over 30-fold higher in patients with CSF1R-mutation-positive ALSP than in age-matched control subjects and serum NfL protein levels were significantly higher in symptomatic patients compared to presymptomatic CSF1R mutation carriers. This evidence concerns the gene NEFL and Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia.